Sowell Financial Services’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
1WCM
MCAV
FCMI
Sowell Financial Services's TXG Position: Q2 2021 in Review
Sowell Financial Services sold out of 10x Genomics (TXG) in Q2 2021, closing a stake of 104 shares — an estimated $15K sold.
Sowell Financial Services first reported a position in TXG in Q3 2020 and held it in 3 quarters. The position peaked at $15K in Q1 2021. 341 funds tracked by Wall St. Rank hold TXG as of Q2 2021.
- Sowell Financial Services reported no remaining 10x Genomics position as of Q2 2021 after selling out during the quarter.
- Sowell Financial Services sold 104 10x Genomics shares in Q2 2021, an estimated $15K.
- Sowell Financial Services first reported a position in 10x Genomics in Q3 2020 and held it in 3 quarters.
- Sowell Financial Services's 10x Genomics position peaked at $15K in Q1 2021.
- 341 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2021.
Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.